PEGS Europe Tablet Banner

Cambridge Healthtech Institute’s 3rd Annual
Analytical Characterisation of Biotherapeutics

Harnessing Technologies and Proven Strategies to Improve Analytics

2 - 3 November 2016 | EPIC SANA Lisboa Hotel | Lisboa PORTUGAL


Analytics play an important role throughout a product’s lifecycle, from candidate lead selection, to preparation for IND and characterizing for lot release. This is even more important with today’s diverse and complex molecules. The ability to characterize these structures, from sequence to higher structure order, is critical to the understanding of the molecules, its function and behavior, as well as its impact on design and further development. Assessment of the critical quality attributes, developability and aggregation propensity, sequence variants, post-translational modifications and higher-order structure hence become a critical component of analytical development.

CHI’s 3rd Annual Analytical Characterization of Biotherapeutics conference arms scientists with the tools that can speed up innovation, and invites scientists with creative strategies and novel techniques to share their ideas, experiences and solutions to support the development of exciting new biotherapeutics.

Preliminary Agenda


EMERGING AND ADVANCED TOOLS AND STRATEGIES FOR CHARACTERIZATION

Characterization of Filgrastim Using Intact and Top-Down MS

Urs Lewandrowski, Ph.D., Lab Head, Analytical Characterization, Sandoz

Advances in Epitope Characterization Using Label-Free Biosensors

Yasmina Abdiche, Ph.D., Research Fellow, Pfizer-Rinat

FTIR Spectroscopy as a Multi-Parameter Analytical Tool for Stability Studies and Batch Consistency Testing of Therapeutic Proteins

Allison Derenne, Ph.D., Researcher, Science-Chemistry, Université libre de Bruxelles

Enhanced Detection of Product-Related Variants and Impurities in Recombinant Glycoproteins

Francois Griaud, Ph.D., Functional Lead Analytics, Biologics Process Development/Late Phase Analytical Development, Novartis Pharma AG


POST-TRANSLATIONAL MODIFICATIONS AND SEQUENCE VARIANCE ANALYSIS

Investigating the Interaction between FcRn and IgG Variants by Hydrogen/Deuterium Exchange Mass Spectrometry

Maximiliane Hilger, Ph.D., Senior Scientist, Mass Spectrometry, Large Molecule Research, Pharma Research and Early Development, Roche Innovation Center Munich


HIGHER ORDER STRUCTURE ANALYSIS

Robust Characterization Methods to Ensure Quality Bioanalytical Assay Reagents

Jihong Yang, Ph.D., Senior Scientist, Bioanalytical Sciences, Genentech

Using Biophysical Methods to Evaluate Protein Higher Order Structures

David Hayes, Ph.D., Principal Scientist, Immune Modulation and Biotherapeutic Discovery, Boehringer Ingelheim


BIOSIMILARITY ASSESSMENT

High Throughput Assays for the Quantification of the Potency and Comparability of Biosimilars and Innovator Products

Michael Tovey, Ph.D., INSERM Director of Research, Laboratory of Biotechnology & Applied Pharmacology, Ecole Normale Supérieure de Cachan

Application of Advanced Methods to Create Analytical Fingerprint of Humira®

Czeslaw Radziejewski, Ph.D., Associate Director, Process Sciences, AbbVie Bioresearch Center

Overcoming Formulation and Analytical Challenges for Developing Biosimilar Products

Jun Liu, Ph.D., Senior Director, Analytical and Pharmaceutical Science, Coherus Bioscience




For more details on the conference, please contact:
Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
T: +1 781.972.5439
E: mlangley@healthtech.com

For exhibit & sponsorship opportunities, please contact:

Companies A-K
Jason Gerardi
Business Development Manager
(+1) 781-972-5452
jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
(+1) 781-972-5471
dinerstein@healthtech.com